Capsida is investigating the root cause of the death, which occurred in the first patient treated in a trial of the company’s ...

TENKASI: Following the death of a 65-year-old woman, the health department officials on Saturday sealed a private clinic at ...

The child was transferred with head and body injuries, eye hemorrhage, and broken ribs, yet the coroner attributed the death ...

The study analyzed over six hundred autopsy-confirmed individuals in data collected by Penn’s Center for Neurodegenerative ...

UK researchers on Wednesday announced the trial of a blood test for Alzheimer's, which it is hoped will transform the ...

Ocaliva, approved for primary biliary cholangitis, faced FDA warnings and restrictions after postmarket data showed higher ...

The letter sender laments that her father — just a year after her mother's death — starts seeing other women again ...

With over three decades of experience in critical care, registered nurse and speaker Raul Meza has released a book that takes ...

Beta-blockers are still crucial for some, but new research calls into question the benefit for a large proportion of patients ...

Raul Meza shares some deep insights in his new book, “Injection of Faith,” a collection of real-life stories about the human ...

Ocaliva won accelerated approval for primary biliary cholangitis in 2016, which the FDA refused to upgrade to full approval ...

3 vs 12 months of dual antiplatelet therapy followed by single antiplatelet therapy was associated with a strong trend ...